GenoQuick CT
Your rapid test system for direct detection of Chlamydia trachomatis from patient samples
Our GenoQuick® CT test system permits rapid and reliable detection of Chlamydia trachomatis DNA directly from patient samples and is therefore ideally suited for use in chlamydia screening. In contrast to other nucleic acid amplification tests, no cost-intensive instrumentation is necessary to perform the GenoQuick® CT . In addition, you can extract bacterial DNA in a time-saving and cost-effective way from first-void urine and cervical smears within approx. 20 minutes using the GenoLyse®.
- Description
Description
Your benefits with GenoQuick® CT
- High sensitivity and specificity: Simultaneous detection of two highly preserved DNA target sequences (MOMP in the C. trachomatis genome, cryptic plasmid) guarantees the reliable detection of C. trachomatis.
- Reliable result: Internal controls document the validity of the result and ensure impeccable testing. A recently discovered Scandinavian mutant with deletion in the cryptic plasmid is also detected.
- Simple interpretation: Positive detection of C. trachomatis is done using a single band on the test strip. The result can thus be seen at a glance.
- Easy-to-use: GenoQuick® technology allows for very little pipette use and optimal suitability for routine use.
- Cost-effective: No cost-intensive instrumentation necessary.
- CE-IVD certified: No need for elaborate validation studies.
At a glance
Rapid molecular genetic assay for the direct detection of Chlamydia trachomatis
Starting material:
first void urine; cervical, urethral, conjunctival swabs, ejaculate and synovial fluid






